Autologous Fat Transfer for Scar Prevention and Remodeling
A Phase I/II Study of Autologous Fat Transfer for Scar Prevention and Remodeling
Sponsor: United States Department of Defense
Listed as NCT01119326, this PHASE1/PHASE2 trial focuses on Wound and remains completed. Sponsored by United States Department of Defense, it has been updated 6 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE1_PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE1_PHASE2
-
Aug 2017 — Jun 2018 [monthly]
Completed PHASE1_PHASE2
Status: Active Not Recruiting → Completed
▶ Show 1 earlier version
-
Jan 2017 — Aug 2017 [monthly]
Active Not Recruiting PHASE1_PHASE2
First recorded
Apr 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- United States Department of Defense
- University of Florida
For direct contact, visit the study record on ClinicalTrials.gov .